SCHEMBL479436

SCHEMBL479436

COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(C(C)(C)N)c(Cl)c1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.40
KMT2A Q03164 6/20 0.40
RAB9A P51151 6/20 0.40
NPC1 O15118 5/20 0.40
MEN1 O00255 5/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.39
TP53 P04637 2/20 0.39
POLB P06746 2/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.36
CDC25A P30304 1/20 0.36
CDC25B P30305 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479819 0.91 RXFP1 (0.44) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL2121532 0.90 KMT2A (0.40) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL480655 0.90 KMT2A (0.40) KMT2ARAB9ANPC1MEN1CTDSP1
SCHEMBL479448 0.89 KMT2A (0.39) KMT2ARAB9ANPC1MEN1CTDSP1
SCHEMBL479595 0.89 BRD4 (0.40) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL479574 0.89 POLB (0.42) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL479616 0.89 NOTUM (0.40) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL2568537 0.88 KMT2A (0.43) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL480718 0.88 KMT2A (0.38) MAPTKMT2ARAB9ANPC1MEN1
SCHEMBL480387 0.86 CASP3 (0.39) MAPTKMT2ARAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF MAPT 960/4885KMT2A 3904/4885RAB9A 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.